Components of a complex substance
Pharmacological Group
Latin name
Oleandomycinum + Tetracyclinum ( Oleandomycini + Tetracyclini).
Used in the treatment of
- N76 Other inflammation of vagina and vulva
- N73 Other female pelvic inflammatory diseases
- N71.9 Inflammatory disease of uterus, unspecified
- N50 Other disorders of male genital organs
- N41.9 Inflammatory disease of prostate, unspecified
- N39.0 Urinary tract infection, site not specified
- N30.9 Cystitis, unspecified
- N12 Tubulo-interstitial nephritis, not specified as acute or chronic
- M86.9 Osteomyelitis, unspecified
- L08.9 Local infection of skin and subcutaneous tissue, unspecified
- K81.9 Cholecystitis, unspecified
- J47 Bronchiectasis
- J40 Bronchitis, not specified as acute or chronic
- J32.9 Chronic sinusitis, unspecified
- J18.0 Bronchopneumonia, unspecified
- J18 Pneumonia, organism unspecified
- J03.9 Acute tonsillitis, unspecified
- J02.9 Acute pharyngitis, unspecified
- J01.9 Acute sinusitis, unspecified
- H66.9 Otitis media, unspecified
- G00.9 Bacterial meningitis, unspecified
- A54 Gonococcal infection
- A46 Erysipelas
- A23.9 Brucellosis, unspecified
- A21.9 Tularaemia, unspecified
Analogs by action
- 76% Tetracycline+Nystatin [Nystatin and more 1Tetracycline]
- 61% Oxytetracycline+Erythromycin [Oxytetracycline and more 1Erythromycin]
- 59% Zinc acetate+Erythromycin [Erythromycin and more 1Zinc acetate]
- 54% Co-trimoxazole [Sulfamethoxazole+Trimethoprim] [Trimethoprim and more 1Sulphamethoxazole]
- Show all